This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2003 Sep 17;290(11):1515-6.

doi: 10.1001/jama.290.11.1515.

Antibiotic therapy for coronary artery disease: can a WIZARD change it all?

Sorin V Pislaru, Frans Van de Werf

PMID: 13129994
DOI: 10.1001/jama.290.11.1515

Editorial

Antibiotic therapy for coronary artery disease: can a WIZARD change it all?

Sorin V Pislaru et al. JAMA. 2003.

. 2003 Sep 17;290(11):1515-6.

doi: 10.1001/jama.290.11.1515.

Authors

Sorin V Pislaru, Frans Van de Werf

PMID: 13129994
DOI: 10.1001/jama.290.11.1515

No abstract available

PubMed Disclaimer

Comment in

Antibiotics and coronary heart disease.
Nieto FJ. Nieto FJ. JAMA. 2004 Jan 21;291(3):302-3; author reply 303. doi: 10.1001/jama.291.3.302-b. JAMA. 2004. PMID: 14734587 No abstract available.

Comment on

Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD; Investigators in the WIZARD Study. O'Connor CM, et al. JAMA. 2003 Sep 17;290(11):1459-66. doi: 10.1001/jama.290.11.1459. JAMA. 2003. PMID: 13129985 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information